Cdk5 and the non-catalytic arrest of the neuronal cell cycle

Cell Cycle

Volumn 7, Issue 22, 2008, Pages 3487-3490

  Zhang, Jie ^a   Herrup, Karl ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Cdk5; Cell cycle suppressor; E2F1; Non catalytic; p27

Indexed keywords

CYCLIN DEPENDENT KINASE 5;

ALZHEIMER DISEASE; CELL CYCLE ARREST; CELL CYCLE PHASE; CELL LINE; CELL MATURATION; CELL MIGRATION; CELL NUCLEUS; CYTOPLASM; DEGENERATIVE DISEASE; DNA DAMAGE; ENZYME ACTIVITY; HUMAN; IMMUNOREACTIVITY; MITOSIS; NERVE CELL; NERVE CELL NECROSIS; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW;

EID: 56449083735     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.7.22.7045     Document Type: Review

References (71)

1. Hellmich MR, Pant HC, Wada E, Battey JF. Neuronal cdc2-like kinase: a cdc2-related protein kinase with predominantly neuronal expression. Proc Natl Acad Sci USA 1992; 89:10867-71.
2. 2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner. J Neurosci 2002; 22:7879-91.
3. Ko J, Humbert S, Bronson RT, Takahashi S, Kulkarni AB, Li E, Tsai LH. p35 and p39 Are Essential for Cyclin-Dependent Kinase 5 Function during Neurodevelopment. J Neurosci 2001; 21:6758-71.
4. Philpott A, Porro EB, Kirschner MW, Tsai LH. The role of cyclin-dependent kinase 5 and a novel regulatory subunit in regulating muscle differentiation and patterning. Genes Dev 1997; 11:1409-21.
5. Gao CY, Zakeri Z, Zhu Y, He H, Zelenka PS. Expression of Cdk5, p35 and Cdk5-associated kinase activity in the developing rat lens. Dev Genet 1997; 20:267-75.
6. Lew J, Huang QQ, Qi Z, Winkfein RJ, Aebersold R, Hunt T, Wang JH. A brain-specific activator of cyclin-dependent kinase 5. Nature 1994; 371:423-6.
7. Tang D, Yeung J, Lee KY, Matsushita M, Matsui H, Tomizawa K, Hatase O, Wang JH. An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator. J Biol Chem 1995; 270:26897-903.
8. Tsai LH, Delalle I, Caviness VS Jr, Chae T, Harlow E. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 1994; 371:419-23.
9. Brown NR, Noble ME, Endicott JA, Johnson LN. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nat Cell Biol 1999; 1:438-43.
10. Shetty KT, Link WT, Pant HC. Cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXKmotifs in neurofilament proteins: isolation characterization. Proc Natl Acad Sci USA 1993; 90:6844-8.
11. Tarricone C, Dhavan R, Peng J, Areces LB, Tsai LH, Musacchio A. Structure and Regulation of the CDK5-p25nck5a Complex. Mol Cell 2001; 8:657-69.
12. Xiong Y, Zhang H, Beach D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992; 71:505-14.
13. Guidato S, McLoughlin DM, Grierson AJ, Miller CC. Cyclin D2 interacts with Cdk5 and modulates cellular Cdk5/p35 activity. J neurochem 1998; 70:335-40.
14. Zhang H, Xiong Y, Beach D. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol Biol Cell 1993; 4:897-906.
15. Miyajima M, Nornes HO, Neuman T. Cyclin E is expressed in neurons and forms complexes with cdk5. Neuroreport 1995; 6:1130-2.
16. Gilmore EC, Ohshima T, Goffinet AM, Kulkarni AB, Herrup K. Cyclin-dependent kinase 5-deficient mice demonstrate novel developmental arrest in cerebral cortex. J Neurosci 1998; 18:6370-7.
17. Paglini G, Pigino G, Kunda P, Morfini G, Maccioni R, Quiroga S, Ferreira A, Caceres A. Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth. J Neurosci 1998; 18:9858-69.
18. Cheng K, Ip NY. Cdk5: a new player at synapses. Neurosignals 2003; 12:180-90.
19. Dhavan R, Tsai LH. A decade of cdk5. Nature Rev Mol Cell Bio 2001; 2:749-59.
20. Meyerson M, Enders GH, Wu CL, Su LK, Gorka C, Nelson C, Harlow E, Tsai LH. A family of human cdc2-related protein kinases. EMBO J 1992; 11:2909-17.
21. van den Heuvel S, Harlow E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 1993; 262:2050-4.
22. al-Ubaidi MR, Hollyfield JG, Overbeek PA, Baehr W. Photoreceptor degeneration induced by the expression of simian virus 40 large tumor antigen in the retina of transgenic mice. Proc Natl Acad Sci USA 1992; 89:1194-8.
23. Feddersen RM, Ehlenfeldt R, Yunis WS, Clark HB, Orr HT. Disrupted cerebellar cortical development and progressive degeneration of Purkinje cells in SV40 T antigen transgenic mice. Neuron 1992; 9:955-66.
24. Herrup K, Yang Y. Cell cycle regulation in the postmitotic neuron: oxymoron or new biology? Nat Rev Neurosci 2007; 8:368-78.
25. Herrup K, Busser JC. The induction of multiple cell cycle events precedes target-related neuronal death. Development 1995; 121:2385-95.
26. Kranenburg O, van der Eb AJ, Zantema A. Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J 1996; 15:46-54.
27. Park DS, Farinelli SE, Greene LA. Inhibitors of cyclin-dependent kinases promote survival of post-mitotic neuronally differentiated PC12 cells and sympathetic neurons. J Biol Chem 1996; 271:8161-9.
28. Gilmore EC, Ohshima T, Goffinet AM, Kulkarni AB, Herrup K. Cyclin-dependent kinase 5-deficient mice demonstrate novel developmental arrest in cerebral cortex. J Neurosci 1998; 18:6370-7.
29. Ohshima T, Gilmore EC, Longenecker G, Jacobowitz DM, Brady RO, Herrup K, Kulkarni AB. Migration defects of cdk5-/- neurons in the developing cerebellum is cell autonomous. J Neurosci 1999; 19:6017-26.
30. Cicero S, Herrup K. Cyclin-dependent kinase 5 is essential for neuronal cell cycle arrest and differentiation. J Neurosci 2005; 25:9658-68.
31. Tsai LH, Takahashi T, Caviness VS Jr, Harlow E. Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development 1993; 119:1029-40.
32. Zhang Q, Ahuja HS, Zakeri ZF, Wolgemuth DJ. Cyclin-dependent kinase 5 is associated with apoptotic cell death during development and tissue remodeling. Dev Biol 1997; 83:222-33.
33. Musa FR, Tokuda M, Kuwata Y, Ogawa T, Tomizawa K, Konishi R, Takenaka I, Hatase O. Expression of cyclin-dependent kinase 5 and associated cyclins in Leydig and Sertoli cells of the testis. J Androl 1998; 19:657-66.
34. O'Hare MJ, Kushwaha N, Zhang Y, Aleyasin H, Callaghan SM, Slack RS, Albert PR, Vincent I, Park DS. Differential roles of nuclear and cytoplasmic cyclin-dependent kinase 5 in apoptotic and excitotoxic neuronal death. J Neurosci 2005; 28:8954-66.
35. Zhang J, Cicero SA, Wang L, Romito-DiGiacomo RR, Yang Y, Herrup K. Nuclear localization of Cdk5 is a key determinant in the post-mitotic state of neurons. Proc Natl Acad Sci USA 2008; 105:8772-7.
36. Wang L, Wang R, Herrup K. E2F1 works as a cell cycle suppressor in mature neurons. J Neurosci 2007; 27:12555-64.
37. Yang Y, Varvel NH, Lamb BT, Herrup K. Ectopic cell cycle events link human Alzheimer's disease and amyloid precursor protein transgenic mouse models. J Neurosci 2006; 26:775-84.
38. Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, Snyder GL, Yan Z, Sagawa ZK, Ouimet CC, Nairn AC, Nestler EJ, Greengard P. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 2001; 410:376-80.
39. Sherr CJ, Roberts JM. Living with or without cyclins and cyclin dependent kinases. Genes Dev 2004; 18:2699-711.
40. 1-phase. Genes Dev 1999; 13:1501-12.
41. Nagy Z. Cell cycle regulatory failure in neurons: causes and consequences. Neurobiol Aging 2000; 21:761-9.
42. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 1994; 372:570-3.
43. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78:59-66.
44. Kip1 for restriction point control of the fibroblast cell cycle. Science 1996; 272:877-80.
45. kip1 contributing to actin organization and cortical neuronal migration. Nature Cell Biol 2006; 8:17-26.
46. Kip1 in neurons. Proc Natl Acad Sci USA 1996; 93:3259-63.
47. Rodier G, Montagnoli A, Di Marcotullio L, Coulombe P, Draetta GF, Pagano M, Meloche S. p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J 2001; 20:6672-82.
48. 1 transition. Mol Cell Biol 2007; 27:4626-40.
49. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E. New functional activities for the p21 family of CDK inhibitors. Genes Dev 1997; 11:847-62.
50. Landis MW, Pawlyk BS, Li T, Sicinski P, Hinds PW. Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis. Cancer Cell 2006; 9:13-22.
51. Benzeno S, Narla G, Allina J, Cheng GZ, Reeves HL, Banck MS, Odin JA, Diehl JA, Germain D, Friedman SL. Cyclin-Dependent Kinase Inhibition by the KLF6 Tumor Suppressor Protein through Interaction with Cyclin D1. Cancer Res 2004; 64:3885-91.
52. Trimarchi JM, Lees JA. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 2002; 3:11-20.
53. Ishida S, Huang E, Zuzan H, Spang R, Leone G, West M, Nevins JR. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol Cell Biol 2001; 21:4684-99.
54. Muller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E, Prosperini E, Vigo E, Oliner JD, Helin K. E2Fs regulate the expression of genes involved in differentiation, development, proliferation and apoptosis. Genes Dev 2001; 15:267-85.
55. Stanelle J, Stiewe T, Theseling CC, Peter M, Putzer BM. Gene expression changes in response to E2F1 activation. Nucleic Acids Res 2002; 30:1859-67.
56. Love S. Neuronal expression of cell cycle-related proteins after brain ischaemia in man. Neurosci Lett 2003; 353:29-32.
57. Nguyen MD, Mushynski WE, Julien JP. Cycling at the interface between neurodevelopment and neurodegeneration. Cell Death Differ 2002; 9:1294-306.
58. Yang Y, Herrup K. Loss of neuronal cell cycle control in ataxia-telangiectasia: a unified disease mechanism. J Neurosci 2005; 25:2522-9.
59. Byrnes KR, Stoica BA, Fricke S, Giovanni SD, Faden AI. Cell cycle activation contributes to post-mitotic cell death and secondary damage after spinal cord injury. Brain 2007; 130:2977-92.
60. Jordan-Sciutto KL, Dorsey R, Chalovich EM, Hammond RR, Achim CL. Expression patterns of retinoblastoma protein in Parkinson disease. J Neuropathol Exp Neurol 2003; 62:68-74.
61. Busser J, Geldmacher DS, Herrup K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J Neurosci 1998; 18:2801-7.
62. Nagy Z, Esiri MM, Cato AM, Smith AD. Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol (Berl) 1997; 94:6-15.
63. Yang Y, Geldmacher DS, Herrup K. DNA replication precedes neuronal cell death in Alzheimer's disease. J Neurosci 2001; 21:2661-8.
64. Yang Y, Mufson EJ, Herrup K. Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. J Neurosci 2003; 23:2557-63.
65. McShea A, Harris PL, Webster KR, Wahl AF, Smith MA. Abnormal expression of the cell cycle regulators p16 and CDK4 in Alzheimer's disease. Am J Pathol 1997; 150:1933-9.
66. Smith MZ, Nagy Z, Esiri MM. Cell cycle-related protein expression in vascular dementia and Alzheimer's disease. Neurosci Lett 1999; 271:45-8.
67. Arendt T, Rodel L, Gartner U, Holzer M. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. Neuroreport 1996; 7:3047-9.
68. Arendt T, Holzer M, Gartner U. Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease. J Neural Transm 1998; 105:949-60.
69. Schwartz EI, Smilenov LB, Price MA, Osredkar T, Baker RA, Ghosh S, Shi FD, Vollmer TL, Lencinas A, Stearns DM, Gorospe M, Kruman II. Cell cycle activation in postmitotic neurons is essential for DNA repair. Cell Cycle 2007; 6:318-29.
70. Kruman I, Wersto R, Cardozo-Pelaez F, Smilenov L, Chan S, Chrest F, Emokpae R, Gorospe M, Mattson M. Cell Cycle Activation Linked to Neuronal Cell Death Initiated by DNA Damage. Neuron 2001; 41:549-61.
71. Cruz JC, Tsai LH. Cdk5 deregulation in the pathogenesis of Alzheimer's disease. Trends Mol Med 2004; 10:452-8.